ELIMINATION OF HEXAMETHYLENE DIISOCYANATE CROSS-LINKED POLYPEPTIDES IN PATIENTS WITH NORMAL OR IMPAIRED RENAL-FUNCTION

被引:14
作者
KOHLER, H [1 ]
KIRCH, W [1 ]
FUCHS, P [1 ]
STALDER, K [1 ]
DISTLER, A [1 ]
机构
[1] UNIV GOTTINGEN, LEHRSTUHL ARBEITS & SOZIALMED, D-3400 GOTTINGEN, FED REP GER
关键词
Colloidal plasma substitutes; cross-linked polypeptides; Haemaccel[!sup]®[!/sup; pharmacokinetics; renal failure;
D O I
10.1007/BF00716381
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Infusions of 3.5% isocyanate cross-linked polypeptide solution 500 ml were given to 52 patients with normal or impaired renal function: glomerular filtration rate (GFR)=0-133 ml/min. The serum concentration and urinary excretion of hydroxyproline were measured and the equivalent polypeptide concentrations were calculated from the results. In patients with normal renal function (GFR>90 ml/min) the proportion of polypeptide excreted in the urine up to 12 h was 45.4±2.6% ( {Mathematical expression}±SEM), up to 24 h 47.7±2.9% and up to 48 h 49.3±3.4%. In patients with moderate renal insufficiency (GFR=30-90 ml/min) there was no decrease in polypeptide excretion and even in patients with more serious impairment of GFR (11-30 ml/min) 48-h urinary polypeptide excretion was still 40.6±5.9%. In patients with GFR of 2-10 ml/min polypeptide excretion fell to 10.7±3.2% during the first 12 h, although there was an increase in later collection periods as compared to patients with normal renal function -19.9±3.9% in 24 h and 27.0±3.5% in 48 h. The elimination half-life (t1/2) calculated from serum concentrations was 505±30 min ( {Mathematical expression}±SEM) in patients with normal renal function (GFR>90 ml/min). Only when the GFR fell below 30 ml/min did it slowly begin to increase. In patients with minimal residual renal function (GFR=0-0.5 ml/min), who were on haemodialysis, the elimination half-life was 985±49 min, i.e. approximately twice the normal. Twice weekly infusion of 3.5% polypeptide solution 500 ml over a period of 6 weeks did not produce any significant cumulation in haemodialysis patients (GFR=0-0.5 ml/min). A weekly dose of polypeptide 35 g appeared to be quite safe when given for several weeks, even to anuric patients. As no significant amount of polypeptide was lost during haemodialysis, the dose can be chosen without taking into account any effect of intermittent haemodialysis. © 1978 Springer-Verlag.
引用
收藏
页码:405 / 412
页数:8
相关论文
共 21 条
  • [11] Kohler H, 1977, Verh Dtsch Ges Inn Med, V83, P1676
  • [12] DOSAGE AND ELIMINATION OF DEXTRAN 40 IN PATIENTS ON HEMODIALYSIS
    KOHLER, H
    WEIHRAUCH, TR
    FIEGEL, P
    KIRCH, W
    HOFFLER, D
    [J]. KLINISCHE WOCHENSCHRIFT, 1975, 53 (11): : 523 - 527
  • [13] KUHN N, 1973, EXPT UNTERSUCHUNGEN
  • [14] METCALF W, 1970, SURG GYNECOL OBSTETR, V131, P255
  • [15] MEASUREMENT OF RESIDUAL GLOMERULAR-FILTRATION RATE IN PATIENT RECEIVING REPETITIVE HEMODIALYSIS
    MILUTINOVIC, J
    CUTLER, RE
    HOOVER, P
    MEIJSEN, B
    SCRIBNER, BH
    [J]. KIDNEY INTERNATIONAL, 1975, 8 (03) : 185 - 190
  • [16] Schiessl J H, 1977, Verh Dtsch Ges Inn Med, V83, P1310
  • [17] SCHMIDTTHOME J, 1962, ARZNEIMITTELFORSCH, V12, P378
  • [18] SCHWARTZKOPFF W, 1968, Zeitschrift fuer die Gesamte Experimentelle Medizin, V147, P202, DOI 10.1007/BF02044606
  • [19] DETERMINATION OF HYDROXYPROLINE
    STEGEMAN.H
    STALDER, K
    [J]. CLINICA CHIMICA ACTA, 1967, 18 (02) : 267 - &
  • [20] MIKROBESTIMMUNG VON HYDROXYPROLIN MIT CHLORAMIN-T UND PARA-DIMETHYLAMINOBENZALDEHYD
    STEGEMANN, H
    [J]. HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1958, 311 (1-3): : 41 - 45